Stockreport

Pulmonx reiterates $90M-$92M 2026 revenue guidance amid cost cuts and expects return to growth in 2H 2026 [Seeking Alpha]

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations
PDF "Pulmonx delivered total worldwide revenue of $20.6 million in the first quarter of 2026" and "we remain confident in our ability to achieve our previously communicated [Read more]